Lastly, we did not extract data on endoscopic or clinical disease activity and IBD therapy, such as use of thiopurines, corticosteroids, or biologicals, as well as a history of blood transfusions, use of erythropoietin-stimulating agents or proton-pump inhibitors. The gene discussed is EPO; the disease is inflammatory bowel disease.